Primary systemic amyloidosis

Journal of Association of Physicians of India

Volumn 52, Issue APR, 2004, Pages 335-337

  Patel, A L ^a   Jayaram, S ^a   Shaikh, W A ^a   Basavaraj, A ^a   Patel, H ^b   Malaviya, A P ^a   Kabra, D ^a   Patil, A ^a   Bhende, N ^a  

^a GRANT MEDICAL COLLEGE   (India)

^b Habib Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; PREDNISOLONE;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; PATHOPHYSIOLOGY; PROGNOSIS;

ADULT; AMYLOIDOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MELPHALAN; PREDNISOLONE; PROGNOSIS;

EID: 13744263984     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Virchow VR. Ueber einem Gehirn and Rueckenmark des Menschen auf gefundene Substanz mit chemischen reaction der Cellulose. Virchows Arh Pathol Anat 1854;6:135-8.
2. Divry P, Florkin M. Sur les prorietes optiques de l'amyloide. C R Seances Soc Biol 1927;97:1808-10.
3. Falk RH, Comenzo RL, Skinner M. The systemic Amyloidosis. N Engl J Med 1997;337:898-909.
4. Kylie RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicines alone, melphalan and prednisolone, and colchicines, melphalan, and prednisolone. N Engl J Med 1997;336:1202-7.
5. Patel AR, Dubery SW, Mendes LA. RV dilatation in primary amyloidosis- An independent predictor of survival. Am J Cardiol 1997;80:466-92.